Search results for "Highlights"
Nearly 5% of adults diagnosed with type 2 diabetes in Scotland were in remission in 2019
Compared with people who did not achieve remission, those in remission tended to be older, to have a lower HbA1c level at diagnosis, to have never taken any glucose-lowering medication, to have lost weight since diabetes diagnosis, and to have had bariatric surgery.
https://diabetes.acponline.org/archives/2021/11/12/1.htm
12 Nov 2021
Type 1 and type 2 diabetes associated with increased risk of herpes zoster
Results of a systematic review and meta-analysis were consistent across age groups, diabetes types, and regions of the world. The study authors suggested that earlier vaccination against herpes zoster in all patients with diabetes, regardless of age, be considered.
https://diabetes.acponline.org/archives/2021/10/08/2.htm
8 Oct 2021
Statins associated with progression of diabetes
A retrospective study of veterans with diabetes found that those who started statin therapy were more likely to meet criteria for diabetes progression, such as initiation of insulin or an additional antihyperglycemic drug class, over time.
https://diabetes.acponline.org/archives/2021/10/08/3.htm
8 Oct 2021
Consensus report issued on management of type 1 diabetes in adults
The report from the American Diabetes Association and European Association for the Study of Diabetes offers guidance on diagnosis, management, and treatment, among other topics. Their recommendations are evidence-based where possible but represent the consensus opinion of the authors.
https://diabetes.acponline.org/archives/2021/10/08/1.htm
8 Oct 2021
Physician-patient discussions may decrease unnecessary self-monitoring of blood glucose levels
In a cross-sectional survey at an Ohio health system, 67% of respondents with non-insulin-controlled type 2 diabetes said they monitored their blood glucose levels because their physician had asked them to, and 50% said they would stop if given permission.
https://diabetes.acponline.org/archives/2021/09/10/2.htm
10 Sep 2021
GLP-1 receptor agonists improved cardiovascular, kidney outcomes in type 2 diabetes
In a systematic review and meta-analysis of eight randomized controlled trials, glucagon-like peptide-1 (GLP-1) receptor agonists reduced major adverse cardiovascular events by 14%, all-cause mortality by 12%, hospital admission for heart failure by 11%, and a composite kidney outcome by 21%, with no increase in safety outcomes.
https://diabetes.acponline.org/archives/2021/09/10/3.htm
10 Sep 2021
Consensus report aims to define remission of diabetes
An international expert group convened by the American Diabetes Association proposed that the criterion for diabetes remission be an HbA1c level below 6.5%, measured at least three months after glucose-lowering drugs are stopped.
https://diabetes.acponline.org/archives/2021/09/10/1.htm
10 Sep 2021
Antidepressant adherence linked to lower risk of advanced complications of diabetes
In patients with diabetes and depression in Taiwan, regular use of an antidepressant was associated with a 0.92-fold decreased risk of macrovascular complications and a 0.86-fold decreased risk of all-cause mortality compared with poor adherence.
https://diabetes.acponline.org/archives/2021/08/13/2.htm
13 Aug 2021
Diets with low glycemic index or glycemic load may benefit patients with diabetes
A systematic review and meta-analysis found small improvements in established targets for glycemic control, blood lipids, adiposity, and inflammation among those with moderately controlled type 1 and type 2 disease who tried low glycemic index/load diets.
https://diabetes.acponline.org/archives/2021/08/13/3.htm
13 Aug 2021
Few diabetes, hypertension patients get recommended testing for kidney disease
Only 21% of patients with diabetes, hypertension, or both underwent urine albumin-to-creatinine ratio testing in a year, despite guideline recommendations, a large recent study found.
https://diabetes.acponline.org/archives/2021/08/13/1.htm
13 Aug 2021